You have 9 free searches left this month | for more free features.

Neoplasms, Experimental

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Healthy Trial in Hangzhou (No intervention)

Recruiting
  • Gastric Cancer
  • Healthy
  • No intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023

HPV, Related Malignancy, Related Carcinoma Trial in Houston (Experimental arm 1, Experimental arm 2, Experimental arm 3)

Recruiting
  • HPV
  • +2 more
  • Experimental arm 1
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Breast Cancer, Liver Metastases Trial in Leuven

Not yet recruiting
  • Breast Cancer
  • Liver Metastases
    • Leuven, Belgium
      Sophia Leduc
    Jan 31, 2023

    Tumor Malignant, Tumor, Experimental, Solid Tumor, Adult Trial in Taipei (JS014, Interleukin 21 and humanized anti-human serum

    Active, not recruiting
    • Neoplasm Malignant
    • +3 more
    • JS014, Interleukin 21 and humanized anti-human serum albumin VHH antibody
    • Pembrolizumab - anti-PD-1 antibody
    • Taipei, Taiwan
      Wanfang Hospital -Taipei Medical University
    Mar 16, 2022

    Early Palliative Care in Pancreatic Cancer -Quasi-experimental

    Active, not recruiting
    • Pancreatic Cancer
    • Palliative care
    • Frederikssund, Denmark
      Nordsjaellands Hospital
    Nov 3, 2022

    Esophageal Cancer Associated Neoantigens

    Not yet recruiting
    • Esophageal Cancer
    • Neoantigen
    • ratio of predicted neoantigens
    • Ho Chi Minh City, Vietnam
      University Medical Center Ho Chi Minh City
    Aug 9, 2022

    Gastric Cancer Associated Neoantigens

    Not yet recruiting
    • Gastric Cancer
    • Neoantigens
    • ratio of predicted neoantigens
    • Ho Chi Minh City, Vietnam
      University Medical Center Ho Chi Minh City
    Aug 9, 2022

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023

    Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node

    Enrolling by invitation
    • Lymph Node Metastasis
    • +6 more
    • Experimental: FOLFOXIRI and Lateral lymph node dissection
    • Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
    Sep 15, 2023

    Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

    Recruiting
    • Protein Kinase Inhibitors
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Nov 9, 2023

    Harvesting Cells for Experimental Cancer Treatments

    Enrolling by invitation
    • Melanoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 6, 2023

      Malignant Tumor Trial (Experimental: DaRT seeds)

      Not yet recruiting
      • Malignant Tumor
      • Experimental: DaRT seeds
      • (no location specified)
      Mar 27, 2023

      Head Neck Cancer Trial in Tilburg (Experimental Intervention)

      Recruiting
      • Head and Neck Cancer
      • Experimental Intervention
      • Tilburg, Noord Brabant, Netherlands
        Instituut Verbeeten
      Aug 3, 2023

      Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Control Arm ACSM Guidelines
      • Experimental Arm 6-12-25 repetitions per set
      • (no location specified)
      Nov 6, 2023

      Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

      Completed
      • Gastric Cancer
      • Arm I : Experimental (Prucalopride succinate group)
      • Arm II : Control (Mosapride citrate group)
      • Seoul, Korea, Republic of
        GangnamSeverance Hospital
      Jul 21, 2023

      Colon Cancer Trial in Málaga (Experimental Treatment, DCOOP Product, Hydroxytyrosol extract, Experimental Treatment,Indukern

      Not yet recruiting
      • Colon Cancer
      • Experimental Treatment, DCOOP Product, Hydroxytyrosol extract
      • +2 more
      • Málaga, Spain
        Hospital Regional Universitario de Málaga
      Jul 21, 2022

      Colorectal Cancer, Monkey Pox Trial in Nanning (Immunohistochemical staining with anti-FOS)

      Recruiting
      • Colorectal Cancer
      • Monkey Pox
      • Immunohistochemical staining with anti-FOS
      • Nanning, Guangxi, China
        Guangxi Medical University Cancer Hospital
      Jan 25, 2023

      Small Cell Lung Cancer Trial in Hangzhou (1.Experimental: A (Part 1): Fluzoparib and SHR -1316, 2.Experimental: B (Part 1):

      Completed
      • Small Cell Lung Cancer
      • 1.Experimental: A (Part 1): Fluzoparib and SHR -1316
      • +2 more
      • Hangzhou, Zhejiang, China
        Cancer Hospital of the University of Chinese Academy of Sciences
      Jun 16, 2022

      Colorectal Cancer, Gastrointestinal Dysfunction Trial in Shanghai (Electroacupuncture group, Sham EA group)

      Not yet recruiting
      • Colorectal Cancer
      • Gastrointestinal Dysfunction
      • Electroacupuncture group
      • Sham EA group
      • Shanghai, Shanghai, China
        Shanghai Yueyang Integrated Medicine Hospital
      Nov 10, 2023

      Oncology Trial in Los Altos

      Recruiting
      • Oncology
        • Los Altos, California
          Cancer Commons
        Jan 31, 2023

        Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

        Not yet recruiting
        • Multiple Myeloma
        • Primary Plasma Cell Leukemia
        • Experimental: CAR-T cells Infusion
        • Shanghai, China
          Shanghai Changzheng Hospital
        Apr 20, 2023

        Hematologic Cancer Trial (experimental:Acute leukemia/myelodysplastic or myeloproliferative disease)

        Not yet recruiting
        • Hematologic Cancer
        • experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
        • (no location specified)
        Oct 26, 2022

        Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

        Recruiting
        • Gynecologic Cancer
        • +3 more
        • Ljubljana, Slovenia
        • +1 more
        Aug 6, 2022

        Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)

        Active, not recruiting
        • Breast Cancer
        • Metal wire
        • Radioactive Iodine Seed
        • Nice, France
          Centre Antoine LACASSAGNE
        Jan 19, 2023

        NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
        • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
        • Tianjing, Tianjin, China
          Tianjin cancer hospital
        Nov 3, 2023